Skip to main content

Table 5 Risk of congenital anomalies among the offspring of RNs according to weighted duration of exposure to antineoplastic drugs (method 2), 1986-2000 (N = 22,491)1,2

From: Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs

Congenital anomaly category

(ICD9 code)

Weighted duration of

exposure3

Exposure during first trimester of

pregnancy

Exposure during 10 years preceding

pregnancy

  

cases

OR4

CI (95%)

cases

OR4

CI (95%)

All congenital anomalies

< 15 days

1,328

1.00

 

1229

1.00

 

(740-759)

≥ 15 days

63

0.93

0.72-1.21

162

0.98

0.82-1.16

Nervous system

< 15 days

51

1.00

 

47

1.00

 

(740-742)

≥ 15 days

< 3

  

6

0.96

0.41-2.24

Eye

< 15 days

89

1.00

 

81

1.00

 

(743)

≥ 15 days

6

1.31

0.57-3.00

14

1.26

0.71-2.22

Ear, face, neck

< 15 days

85

1.00

 

82

1.00

 

(744)

≥ 15 days

4

0.96

0.35-2.64

7

0.64

0.30-1.39

Heart

< 15 days

137

1.00

 

127

1.00

 

(745-746)

≥ 15 days

10

1.44

0.75-2.74

20

1.15

0.72-1.84

Other circulatory system

< 15 days

127

1.00

 

115

1.00

 

(747)

≥ 15 days

8

1.26

0.61-2.58

20

1.28

0.79-2.06

Cleft palate/lip

< 15 days

29

1.00

 

25

1.00

 

(749)

≥ 15 days

< 3

  

6

1.84

0.75-4.49

Upper alimentary tract

< 15 days

83

1.00

 

81

1.00

 

(750)

≥ 15 days

4

0.93

0.34-2.55

6

0.55

0.24-1.25

Other digestive system

< 15 days

35

1.00

 

32

  

(751)

≥ 15 days

< 3

  

5

1.17

0.46-3.01

Genital organs

< 15 days

213

1.00

 

192

1.00

 

(752)

≥ 15 days

6

0.55

0.24-1.25

27

1.06

0.70-1.59

Urinary system

< 15 days

101

1.00

 

93

1.00

 

(753)

≥ 15 days

5

0.97

0.39-2.38

13

1.05

0.59-1.88

Musculoskeletal system

< 15 days

443

1.00

 

419

1.00

 

(754-756)

≥ 15 days

18

0.80

0.49-1.28

42

0.74

0.54-1.02

Integument

< 15 days

96

1.00

 

88

1.00

 

(228, 757)

≥ 15 days

5

1.01

0.41-2.49

13

1.08

0.60-1.94

Chromosomal anomalies

< 15 days

60

1.00

 

56

1.00

 

(758)

≥ 15 days

< 3

  

4

0.54

0.20-1.49

Multiple anomalies

< 15 days

15

1.00

 

13

1.00

 

(759.7-759.8)

≥ 15 days

< 3

  

3

1.76

0.50-6.19

  1. 1 Congenital anomalies with an incidence of less than 3 cases were excluded.
  2. 2 N for ≥ 15 days of antineoplastic drug exposure during first trimester of pregnancy = 1,062; during 10 years preceding pregnancy = 2,650.
  3. 3 A weighted duration of exposure of 15 days is equivalent to full-time work for one year (240 days) at a job considered unlikely to be exposed; a weighted duration of exposure of 60 days is equivalent to full-time work for one year at a job considered possibly exposed.
  4. 4 Adjusted for sex, year of birth, and age of mother.